MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohort

Journal of Neurotrauma

Volumn 28, Issue 9, 2011, Pages 1739-1745

  Scher, Ann I ^a   Wu, Holly ^a   Tsao, Jack W ^b   Blom, Henk J ^c   Feit, Preethy ^a   Nevin, Remington L ^d   Schwab, Karen A ^e  

^a Uniformed Services University of the Health Sciences   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Bayne Jones Army Community Hospital   (United States)

^e Defense and Veterans Brain Injury Center   (United States)

Author keywords

epidemiology; epilepsy; folate; head injury; homocysteine; migraine; MTHFR C677T; post traumatic seizure; traumatic brain injury

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARMY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SENSITIVITY ANALYSIS; TRAUMATIC EPILEPSY;

ADULT; BRAIN INJURIES; EPILEPSY; EPILEPSY, POST-TRAUMATIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MILITARY PERSONNEL; RISK FACTORS;

EID: 80054800599     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.1982     Document Type: Article

References (39)

1. Apeland, T., Mansoor, M.A, Pentieva, K., McNulty, H., and Strandjord, R.E. (2003). Fasting and post-methionine loading concentrations of homocysteine, vitamin B2, and vitamin B6 in patients on antiepileptic drugs. Clin. Chem. 49, 1005-1008.
2. Bigal, M.E., Lipton, R.B, Cohen, J., and Silberstein, S.D. (2003). Epilepsy and migraine. Epilepsy Behav. 4(Suppl. 2), S13-S24.
3. Bleich, S., Degner, D., Sperling, W., Bonsch, D., Thurauf, N., and Kornhuber, J. (2004). Homocysteine as a neurotoxin in chronic alcoholism. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 453-464.
4. Botto, L.D. and Yang, Q. (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am. J. Epidemiol. 151, 862-877.
5. Caccamo, D., Condello, S., Gorgone, G., Crisafulli, G., Belcastro, V., Gennaro, S., Striano, P., Pisani, F., and Ientile, R. (2004). Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. Neuromolecular Med. 6, 117-126.
6. Cavalleri, G.L., Weale, M.E., Shianna, K.V., Singh, R., Lynch, J.M., Grinton, B., Szoeke, C., Murphy, K., Kinirons, P., O'Rourke, D., Ge, D., Depondt, C., Claeys, K.G., Pandolfo, M., Gumbs, C., Walley, N., McNamara, J., Mulley, J.C., Linney, K.N., Sheffield, L.J., Radtke, R.A., Tate, S.K., Chissoe, S.L., Gibson, R.A., Hosford, D., Stanton, A., Graves, T.D., Hanna, M.G., Eriksson, K., Kantanen, A.M., Kalviainen, R., O'Brien, T.J., Sander, J.W., Duncan, J.S., Scheffer, I.E., Berkovic, S.F., Wood, N.W., Doherty, C.P., Delanty, N., Sisodiya, S.M., and Goldstein, D.B. (2007). Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: A case-control study. Lancet Neurol. 6, 970-980.
7. Cronin, S., Furie, K.L., and Kelly, P.J. (2005). Dose-related association of MTHFR 677T allele with risk of ischemic stroke: Evidence from a cumulative meta-analysis. Stroke 36, 1581-1587.
8. de Bree, A., Verschuren, W.M., Bjorke-Monsen, A.L., van der Put, N.M., Heil, S.G., Trijbels, F.J., and Blom, H.J. (2003). Effect of the methylenetetrahydrofolate reductase 677C-> T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am. J. Clin. Nutr. 77, 687-693.
9. Dean, J.C., Moore, S.J., Osborne, A., Howe, J., and Turnpenny, P.D. (1999). Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin. Genet. 56, 216-220.
10. Dean, J.C., Robertson, Z., Reid, V., Wang, Q., Hailey, H., Moore, S., Rasalam, A.D., Turnpenny, P., Lloyd, D., Shaw, D., and Little, J. (2007). A high frequency of the MTHFR 677C > T polymorphism in Scottish women with epilepsy: Possible role in pathogenesis. Seizure 17, 269-275.
11. Diaz-Arrastia, R. (2000). Homocysteine and neurologic disease. Arch. Neurol. 57, 1422-1427.
12. Esfahani, S.T., Cogger, E.A., and Caudill, M.A. (2003). Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J. Am. Diet Assoc. 103, 200-207.
13. Greenberg, D.A. and Pal, D.K. (2007). The state of the art in the genetic analysis of the epilepsies. Curr. Neurol. Neurosci. Rep. 7, 320-328.
14. Headquarters Department of the Army (2008). Army Regulation 40-501, Standards of Medical Fitness.
15. Helbig, I., Scheffer, I.E., Mulley, J.C., and Berkovic, S.F. (2008). Navigating the channels and beyond: Unravelling the genetics of the epilepsies. Lancet Neurol. 7, 231-245.
16. Hillemacher, T., Frieling, H., Bayerlein, K., Wilhelm, J, Kornhuber, J., and Bleich, S. (2007). Biological markers to predict previous alcohol withdrawal seizures: A risk assessment. J. Neural Transm. 114, 151-154.
17. Jette, N., Reid, A.Y., Quan, H., Hill, M.D., and Wiebe, S. (2010). How accurate is ICD coding for epilepsy? Epilepsia 51, 62-69.
18. Kini, U., Lee, R., Jones, A., Smith, S., Ramsden, S., Fryer, A., and Clayton-Smith, J. (2007). Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur. J. Med. Genet. 50, 411-420.
19. Kruman, I.I., Culmsee, C., Chan, S.L., Kruman, Y., Guo, Z., Penix, L., and Mattson, M.P. (2000). Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20, 6920-6926.
20. Kubova, H., Folbergrova, J., and Mares, P. (1995). Seizures induced by homocysteine in rats during ontogenesis. Epilepsia 36, 750-756.
21. Langlois, J.A., Rutland-Brown, W., and Thomas, K.E. (2006). Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. Atlanta, GA, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
22. Lewis, S.J., Ebrahim, S., and Davey, S.G. (2005). Meta-analysis of MTHFR 677C-> T polymorphism and coronary heart disease: Does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 331, 1053.
23. Lievers, K.J., Kluijtmans, L.A., and Blom, H.J (2003). Genetics of hyperhomocysteinaemia in cardiovascular disease. Ann. Clin. Biochem. 40, 46-59.
24. Ludvigsson, P., Hesdorffer, D., Olafsson, E., Kjartansson, O., and Hauser, W.A. (2006). Migraine with aura is a risk factor for unprovoked seizures in children. Ann. Neurol. 59, 210-213.
25. Lutz, U.C., Batra, A., Kolb, W., Machicao, F., Maurer, S., and Kohnke, M.D. (2006). Methylenetetrahydrofolate reductase C677T-polymorphism and its association with alcohol withdrawal seizure. Alcoholism Clin. Exper. Res. 30, 1966-1971.
26. Mares, P., Haugvicova, R., and Kubova, H. (2002). Interaction of excitatory amino acid agonists with cortical afterdischarges in developing rats. Epilepsia 43(Suppl. 5), 61-67.
27. Mattson, M.P., and Shea, T.B. (2003). Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 26, 137-146.
28. Ono, H., Sakamoto, A., Mizoguchi, N., and Sakura, N. (2000). Methylenetetrahydrofolate reductase 677C > T mutation and epilepsy. J. Inherit. Metab. Dis. 23, 525-526.
29. Ottman, R., and Lipton, R.B (1994). Comorbidity of migraine and epilepsy. Neurology 44, 2105-2110.
30. Rubertone, M.V., and Brundage, J.F. (2002). The Defense Medical Surveillance System and the Department of Defense serum repository: Glimpses of the future of public health surveillance. Am. J. Public Health 92, 1900-1904.
31. Rubino, E., Ferrero, M., Rainero, I., Binello, E., Vaula, G., and Pinessi, L. (2007). Association of the C677T polymorphism in the MTHFR gene with migraine: A meta-analysis. Cephalalgia 29, 807-808.
32. Schneider, J.A., Rees, D.C., Liu, Y.T., and Clegg, J.B. (1998). Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am. J. Hum. Genet. 62, 1258-1260.
33. Schurks, M., Rist, P.M., and Kurth, T. (2010). MTHFR 677C > T and ACE D/I polymorphisms in migraine: A systematic review and meta-analysis. Headache 50, 588-599.
34. Silverberg, M.J., Brundage, J.F., and Rubertone, M.V. (2003). Timing and completeness of routine testing for antibodies to human immunodeficiency virus type 1 among active duty members of the U.S. Armed Forces. Mil. Med. 168, 160-164.
35. Sniezawska, A., Dorszewska, J., Rozycka, A., Przedpelska-Ober, E., Lianeri, M., Jagodzinski, P.P., and Kozubski, W. (2011). MTHFR, MTR, and MTHFD1 gene polymorphisms compared to homocysteine and asymmetric dimethylarginine concentrations and their metabolites in epileptic patients treated with antiepileptic drugs. Seizure 20, 533-540.
36. Tan, N.C., and Berkovic, S.F. (2010). The Epilepsy Genetic Association Database (epiGAD): Analysis of 165 genetic association studies, 1996-2008. Epilepsia 51, 686-689.
37. Tan, N.C., Mulley, J.C., and Berkovic, S.F. (2004). Genetic association studies in epilepsy: ''the truth is out there.'' Epilepsia 45, 1429-1442.
38. Thurman, D., and Guerrero, J. (1999). Trends in hospitalization associated with traumatic brain injury. JAMA 282, 954-957.
39. Yoo, J.H., and Hong, S.B. (1999). A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism 48, 1047-1051.